- Home
- BIIB vs WDC Comparison
BIIB vs WDC Comparison
Compare BIIB & WDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIIB
- WDC
- Stock Information
- Founded
- BIIB 1978
- WDC 1970
- Country
- BIIB United States
- WDC United States
- Employees
- BIIB N/A
- WDC N/A
- Industry
- BIIB Biotechnology: Pharmaceutical Preparations
- WDC Electronic Components
- Sector
- BIIB Health Care
- WDC Technology
- Exchange
- BIIB Nasdaq
- WDC Nasdaq
- Market Cap
- BIIB 25.1B
- WDC 24.7B
- IPO Year
- BIIB 1991
- WDC N/A
- Fundamental
- Price
- BIIB $149.78
- WDC $61.96
- Analyst Decision
- BIIB Buy
- WDC Buy
- Analyst Count
- BIIB 26
- WDC 21
- Target Price
- BIIB $248.00
- WDC $87.89
- AVG Volume (30 Days)
- BIIB 1.6M
- WDC 6.0M
- Earning Date
- BIIB 02-11-2025
- WDC 01-23-2025
- Dividend Yield
- BIIB N/A
- WDC N/A
- EPS Growth
- BIIB 10.05
- WDC N/A
- EPS
- BIIB 11.06
- WDC 0.99
- Revenue
- BIIB $9,607,500,000.00
- WDC $14,348,000,000.00
- Revenue This Year
- BIIB N/A
- WDC $31.21
- Revenue Next Year
- BIIB N/A
- WDC $10.85
- P/E Ratio
- BIIB $13.47
- WDC $62.16
- Revenue Growth
- BIIB N/A
- WDC 26.61
- 52 Week Low
- BIIB $145.07
- WDC $48.96
- 52 Week High
- BIIB $268.30
- WDC $81.55
- Technical
- Relative Strength Index (RSI)
- BIIB 31.81
- WDC 37.28
- Support Level
- BIIB $145.07
- WDC $58.99
- Resistance Level
- BIIB $149.92
- WDC $67.20
- Average True Range (ATR)
- BIIB 3.57
- WDC 2.14
- MACD
- BIIB 0.18
- WDC -0.83
- Stochastic Oscillator
- BIIB 22.27
- WDC 19.65
About BIIB Biogen Inc.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.
About WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.